home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.78 +0.15 (+0.15%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge

February 02, 2024

--News Direct--

Via News Direct

Topics Death

2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge ↗

February 01, 2024

The global population is experiencing a scary increase in colorectal cancer, especially among young people. Colorectal cancer (CRC) diagnoses have been steadily rising since the 1990s; in 1995 the...

Via Benzinga

Topics Death

Exact Sciences Schedules Fourth Quarter 2023 Earnings Call

February 01, 2024

From Exact Sciences Corp.

Via Business Wire

3 Stocks to Buy for the Age of Personalized Medicine ↗

January 28, 2024

Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.

Via InvestorPlace

A Glimpse Into The Expert Outlook On Exact Sciences Through 5 Analysts ↗

January 02, 2024

Via Benzinga

5 Analysts Have This to Say About Exact Sciences ↗

December 14, 2023

Via Benzinga

2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul ↗

January 22, 2024

These stocks can reward patient investors.

Via The Motley Fool

The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market ↗

January 18, 2024

With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.

Via InvestorPlace

Time to buy these 3 healthcare companies that raised revenue guidance?

January 16, 2024

The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.

Via MarketBeat

Cathie Wood's Ark Invest Acquires Over $25.5 Million Worth Of Tesla Shares — Sells Coinbase And Robinhood Stock A Day After Bitcoin Spot ETF Approval ↗

January 12, 2024

On Thursday, Cathie Wood-led Ark Invest made a significant move in the stock market, purchasing $25.55 million worth of shares in Tesla Inc (NASDAQ:TSLA).

Via Benzinga

Topics ETFs

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024 ↗

January 08, 2024

Small cap stocks are anticipated to rise by as much as 50% in 2024 as investors look for growth in new areas of the market.

Via InvestorPlace

Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock ↗

January 02, 2024

Via Benzinga

Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? ↗

December 20, 2023

Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs.

Via Benzinga

What's Going On With Exact Sciences Stock? ↗

December 20, 2023

Exact Sciences Corporation (NASDAQ: EXAS) shares are trading higher Wednesday, and the stock has gained over 8% in the past month. Here's a look at the latest Exact Sciences news: What To Know:

Via Benzinga

Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday ↗

December 20, 2023

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday.

Via Benzinga

Topics Stocks

Is This BioTech Play Severely Undervalued? BioTech Shares Promising Results From Colorectal Study ↗

December 19, 2023

Via Benzinga

1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest ↗

December 17, 2023

If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right?

Via The Motley Fool

Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences? ↗

December 13, 2023

Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.

Via The Motley Fool

3 Stocks at the Forefront of Personalized Medicine Trend ↗

December 05, 2023

Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly

Via InvestorPlace

A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest ↗

November 26, 2023

If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right?

Via The Motley Fool

The 3 Best Digital Health Stocks for Personalized Medicine ↗

November 25, 2023

Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.

Via InvestorPlace

Cathie Wood's Ark Invest Buys $12.6M Of Zoom Shares Following Positive Earnings ↗

November 22, 2023

Via Benzinga

3 Biotech Stocks With Big-Time Breakthrough Potential ↗

November 20, 2023

The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave.

Via InvestorPlace

2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030 ↗

November 20, 2023

Don't miss out on these potentially market-beating stocks.

Via The Motley Fool

Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent ↗

November 17, 2023

Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S.

Via Benzinga

Topics Intellectual Property Lawsuit

3 Stocks to Love Despite All of the Wall Street Hate ↗

November 14, 2023

We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar.

Via InvestorPlace

7 Biotech Stocks to Buy for Big-Time Gains ↗

November 10, 2023

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript ↗

November 02, 2023

EXAS earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth ↗

November 01, 2023

The company makes a diagnostic tool to detect colon cancer.

Via Investor's Business Daily

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com